New HHS program 1st to link data from mothers and newborns to improve outcomes, reduce disparities
Patient Safety & Outcomes
People with a specific version of a gene known as LTZFL1 may be at increased risk of respiratory failure from COVID-19, according to research published Nov. 4 in Nature.
A solid foundation of research has shown that men are more likely to die of COVID-19 than women, but the reason for this disparity is still unknown.
The National Institutes of Health will follow up to 1,500 pregnant COVID-19 patients and their offspring for four years to study the potential long-term effects of the infection.
New York-based Hospital for Special Surgery is the first hospital in the U.S. to implement CLEAR's Health Pass, a mobile experience that verifies proof of vaccination, to improve health screenings following a successful pilot program, according to a Nov. 3…
Overweight or obese adolescents and adults experience more respiratory symptoms from COVID-19 despite similar viral loads compared with normal-weight individuals, according to a study published Oct. 19 in Influenza and Other Respiratory Viruses.
While a previous bout with COVID-19 offers some immune protection from a subsequent infection, the protection from vaccination is stronger, the CDC's Oct. 29 Morbidity and Mortality Weekly Report suggests.
Certain types of cells in the inner ear produce the proteins needed for SARS-CoV-2 entry — a potential explanation for why some COVID-19 patients experience audiovestibular symptoms, according to research published Oct. 29 in Communications Medicine.
Pregnant and breastfeeding women generate a weaker immune response after their first COVID-19 dose relative to nonpregnant women of similar ages, according to a recent study published in Science Translational Medicine.
While individuals with severe allergies reported more reactions after receiving a COVID-19 mRNA vaccine than those without allergies, nearly all were able to safely complete the series, according to an Oct. 27 study in JAMA Network Open.